AbbVie Clinical domain Oncology / Hematology Clinical indication Multiple myeloma (MM) | Plasma cell myeloma Development status Phase I CAS 1826819-58-2 UNII (FDA) 6XQ9TM3U2G Drug description Immunoglobulin G1, anti-(human CD319 antigen) (human-mus musculus monoclonal PR-1471272 heavy chain),...